Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -128.57% vs 75.00% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 28.88% vs 16.89% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 17.57% vs 10.30% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -70.59% vs -41.38% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Enorama Pharma AB With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -128.57% vs 75.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -102.67% vs 7,400.00% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 28.88% vs 16.89% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -87.32% vs 45.38% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 17.57% vs 10.30% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -258.82% vs 69.64% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -70.59% vs -41.38% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -62.96% vs 440.00% in Sep 2024






